Gastrointestinal pharmacology: Irritable bowel syndrome

Current Opinion in Pharmacology

Volumn 5, Issue 6 SPEC. ISS., 2005, Pages 583-588

  Bueno, Lionel ^a  

^a CEMAGREF   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ALOSETRON; ANTIDEPRESSANT AGENT; ANTIDIARRHEAL AGENT; BULKING AGENT; CHOLINERGIC RECEPTOR BLOCKING AGENT; CILANSETRON; CIMETROPIUM; CJ 1174; DIGESTIVE TRACT SPASMOLYTIC AGENT; GRANISETRON; ISPAGULA; LAXATIVE; LOPERAMIDE; MEBEVERINE; MEN 10930; NEPADUTANT; NOLPITANTIUM; ONDANSETRON; OTILONIUM BROMIDE; PAROXETINE; PINAVERIUM; RENZAPRIDE; SEROTONIN 3 ANTAGONIST; SEROTONIN 4 AGONIST; SEROTONIN UPTAKE INHIBITOR; TACHYKININ RECEPTOR ANTAGONIST; TEGASEROD; TRICYCLIC ANTIDEPRESSANT AGENT; TRIMEBUTINE; UNCLASSIFIED DRUG; UNINDEXED DRUG;

ABDOMINAL PAIN; BILIARY TRACT DISEASE; CLINICAL TRIAL; CONSTIPATION; DIARRHEA; DISEASE EXACERBATION; DRUG MECHANISM; GASTROINTESTINAL TRANSIT; HUMAN; HYPERALGESIA; IMMUNE SYSTEM; IRRITABLE COLON; ISCHEMIC COLITIS; NERVE ENDING; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVIEW; VISCERAL PAIN;

EID: 27744453702     PISSN: 14714892     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.coph.2005.06.006     Document Type: Review

References (36)

1. K.B. Klein Controlled treatment trials in the irritable bowel syndrome: a critique Gastroenterology 95 1988 232-241
2. C.J. Bijkerk J.W.M. Muris J.A. Knottnerus A.W. Hoes N.J. de Wit Systematic review: The role of different types of fibre in the treatment of irritable bowel syndrome Aliment Pharmacol Ther 19 2004 245-251
3. P.S. Efskind T. Bernklev M.H. Vatn A double-blind placebo-controlled trial with loperamide in irritable bowel syndrome Scand J Gastroenterol 31 1996 463-468
4. T. Poynard S. Naveau B. Mory J.C. Chaput Meta-analysis of smooth muscle relaxants in the treatment of irritable bowel syndrome Aliment Pharmacol Ther 8 1994 499-510
5. T. Poynard C. Regimbeau Y. Benhamou Meta-analysis of smooth muscle relaxants in the treatment of irritable bowel syndrome Aliment Pharmacol Ther 15 2001 355-361
6. J.L. Jackson P.G. O'Malley G. Tomkins E. Balden J. Santoro K. Kroenke Treatment of functional gastrointestinal disorders with antidepressant medicaments: A meta-analysis Am J Med 108 2000 65-72
7. D.A. Gerard G.W. Libby MJ.G. Farthing 5 hydroxytryptamine and human small intestinal motility effect of inhibiting 5-hydroxytryptamine uptake Gut 34 1994 496-500
8. R.C. Spiller D. Jenkins J.P. Thornley J.M. Hebden T. Wright M. Skinner K.R. Neal Increased rectal mucosal enteroendocrine cells, T lymphocytes, and increased gut permeability following acute Campylobacter enteritis and in post-dysenteric irritable bowel syndrome Gut 47 2000 804-811
9. A. Yeo P. Boyd S. Lumsden T. Saunders A. Handley M. Stubbins A. Knaggs S. Asquith I. Taylor B. Bahari et al. Association between a functional polymorphism in the serotonin transporter gene and diarrhoea predominant irritable bowel syndrome in women Gut 53 2004 1452-1458
10. 3 antagonist (ondansetron) on rectal sensitivity and compliance in health and the irritable bowel syndrome Aliment Pharmacol Ther 7 1993 543-551
11. M. Camilleri W.Y. Chey E.A. Mayer A randomized controlled clinical trial of the serotonin type 3 receptor antagonist alosetron in women with diarrhea-predominant irritable bowel syndrome Arch Intern Med 161 2001 1733-1740
12. W.D. Chey B.D. Cash Cilansetron: A new serotonergic agent for the irritable bowel syndrome with diarrhea Expert Opin Investig Drugs 14 2005 185-193
13. M. Camilleri Review article: Tegaserod Aliment Pharmacol Ther 15 2001 277-289
14. P. Shoenfeld Systematic review: Incidence of abdominal/pelvic surgery amongst patients using tegaserod in randomized controlled trials Aliment Pharmacol Ther 19 2004 263-269
15. M. Camilleri S. McKinzie J. Fox A. Foxx-Orenstein D. Burton G. Thomforde K. Baxter A.R. Zinsmeister Effect of renzapride on transit in constipation-predominant irritable bowel syndrome Clin Gastroenterol Hepatol 2 2004 895-904
16. M. Camilleri Treating irritable bowel syndrome: Overview, perspective and future therapies Br J Pharmacol 141 2004 1237-1248
17. V. Julia X. Su L. Bueno G.F. Gebhart Role of neurokinin 3 receptors on responses to colorectal distention in the rat: Electrophysiological and behavioral studies Gastroenterology 116 1999 1124-1131
18. J. Fioramonti E. Gaultier M. Toulouse G.J. Sanger L. Bueno Intestinal anti-nociceptive behaviour of NK3 receptor antagonism in conscious rats: evidence to support a peripheral mechanism of action Neurogastroenterol Motil 15 2003 363-399
19. M. Camilleri Alvimopan, a selective peripherally acting mu-opioid antagonist Neurogastroenterol Motil 17 2005 157-165
20. M. Delvaux A. Beck J. Jacob H. Bouzamondo F.T. Weber J. Frexinos Effect of asimadoline, a kappa opioid agonist, on pain induced by colonic distension in patients with irritable bowel syndrome Aliment Pharmacol Ther 20 2004 237-246
21. F. Cremonini M. Camilleri S. McKinzie P. Carlson C.E. Camilleri D. Burton G. Thomforde R. Urrutia A.R. Zinsmeister Effect of CCK-1 antagonist, dexloxiglumide, in female patients with irritable bowel syndrome: A pharmacodynamic and pharmacogenomic study Am J Gastroenterol 100 2005 652-663
22. D.T. Chalmers T.W. Lovenberg D.E. Grigoriadis D.P. Behan E.B. De Souza Corticotrophin-releasing factor receptors: From molecular biology to drug design Trends Pharmacol Sci 17 1996 166-172
23. A.J. Lawrence E.V. Krstew F.M. Dautzenberg A. Ruhmann The highly selective CRF(2) receptor antagonist K41498 binds to presynaptic CRF(2) receptors in rat brain Br J Pharmacol 136 2002 896-904
24. M. Gue C. Del Rio-Lacheze H. Eutamene V. Theodorou J. Fioramonti L. Bueno Stress-induced visceral hypersensitivity to rectal distension in rats: Role of CRF and mast cells Neurogastroenterol Motil 9 1997 271-279
25. I. Castagliuolo J.T. Lamont B. Qiu S.M. Fleming K.R. Bhaskar S.T. Nikulasson C. Kornetsky C. Pothoulakis Stress causes mucin release from rat colon: Role of corticotropin releasing factor and mast cells Am J Physiol 271 1996 G884-G892
26. K. Karalis H. Sano J. Redwine S. Listwak R.L. Wilder G.P. Chrousos Autocrine or paracrine inflammatory actions of corticotropin-releasing hormone in vivo Science 254 1991 421-423
27. L.J. Crofford H. Sano K. Karalis T.C. Friedman H.R. Epps E.F. Remmers P. Mathern G.P. Chrousos R.L. Wilder Corticotropin-releasing hormone in synovial fluids and tissues of patients with rheumatoid arthritis and osteoarthritis J Immunol 151 1993 1587-1596
28. C. Maillot M. Million J.Y. Wei A. Gauthier Y. Tache Peripheral corticotropin-releasing factor and stress-stimulated colonic motor activity involve type 1 receptor in rats Gastroenterology 119 2000 1569-1579
29. A. Ait-Belgnaoui S. Bradesi J. Fioramonti V. Theodorou L. Bueno Acute stress-induced hypersensitivity to colonic distension depends upon increase in paracellular permeability: Role of myosin light chain kinase Pain 113 2005 141-147
30. B. Coulie L.A. Szarka M. Camilleri D.D. Burton S. McKinzie N. Stambler J.M. Cedarbaum Recombinant human neurotrophic factors accelerate colonic transit and relieve constipation in humans Gastroenterology 119 2000 41-50
31. N. Dmitrieva D. Shelton A.S. Rice S.B. McMahon The role of nerve growth factor in a model of visceral inflammation Neuroscience 78 1997 449-459
32. L. Delafoy F. Raymond A.M. Doherty A. Eschalier L. Diop Role of nerve growth factor in the trinitrobenzene sulfonic acid-induced colonic hypersensitivity Pain 105 2003 489-497
33. F. Barreau C. Cartier J. Fioramonti L. Bueno Nerve growth factor mediates alterations of colonic sensitivity and mucosal barrier induced by neonatal stress in rats Gastroenterology 127 2004 524-534
34. C.U. Corvera O. Dery K. McConalogue S.K. Bohm L.M. Khitin G.H. Caughey D.G. Payan N.W. Bunnett Mast cell tryptase regulates rat colonic myocytes through proteinase-activated receptor 2 J Clin Invest 100 1997 1383-1393
35. A.M. Coelho N. Vergnolle B. Guiard J. Fioramonti L. Bueno Proteinases and proteinase-activated receptor 2: A possible role to promote visceral hyperalgesia in rats Gastroenterology 122 2002 1035-1047
36. G. Barbara V. Stanghellini R. De Giorgio C. Cremon G.S. Cottrell D. Santini G. Pasquinelli A.M. Morselli-Labate E.F. Grady N.W. Bunnett et al. Activated mast cells in proximity to colonic nerves correlate with abdominal pain in irritable bowel syndrome Gastroenterology 126 2004 693-702